Standard Therapies - Cord Blood

Similar documents
INFORMATION KIT H PE. IS IN YOUR NEWBORN S BLOOD Help it last a lifetime with cord blood banking. Save $300 with Promo Code.

Family Medical History Questionnaire (FMHQ)

CordLife Secures US Department of Defense Contract

Donating your baby s cord to a public cord blood bank can save lives globally.

What are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS

HEMATOPOIETIC CELL TRANSPLANTATION FOR GENETIC DISEASES AND ACQUIRED ANEMIAS

Sub-Class Code Sub-Classification Other code. Bone Marrow failures including 7 Aplastic Anaemia 77 Other 1 Acquired. Pure red cell aplasia (non

Recommended Timing for Transplant Consultation

Corporate Medical Policy

APBMT Registry LMD Disease classification sheet

Applications of Cord Blood Stem Cells

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

4000: Cellular Therapy Essential Data Pre-Infusion Form

STEMCYTE INDIA s impeccable transplant record (Unmatched in Cord Blood industry)

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

Give Birth to Hope: An Unique Approach to Public Cord Blood Donation

BMTCN Review Course Basic Concepts and Indications for Transplantation How the Experts Treat Hematologic Malignancies Las Vegas, NV, March 10, 2016

Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias

MP Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias

Clinical Utility. Clinical Utility of the Automated IG-Count Xavier Troussard

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

A GLOBAL REGENERATIVE THERAPEUTICS COMPANY. A Commitment to EXCELLENCE. IMPECCABLE TRANSPLANT RECORD Unmatched in cord blood industry

MYELODYSPLASTIC AND MYELOPROLIFERATIVE

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Sub-Class Code Sub-Classification Other code Other classification. Bone Marrow failures including 7 Aplastic Anaemia 77 Other 1 Acquired

Policy #: 190 Original policy date: 6/1/2010 Page: 1 of 9 Revised date: 5/1/2012

Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias

Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias

Sub-Class Code Sub-Classification Other code Other classification. Bone Marrow failures including 7 Aplastic Anaemia 77 Other 1 Acquired

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Policy Specific Section:

babycell.in SMS Babycell to 56677

Sub-Class Code Sub-Classification Other code Other classification. Bone Marrow failures including 7 Aplastic Anaemia 77 Other 1 Acquired

MEDICAL POLICY SUBJECT: ALLOGENEIC STEM CELL TRANSPLANTATION

No Other Company Discloses Higher Transplant Survival Rate. Infusions For Emerging Treatments. Date of Use. Recipient Age (yrs)

Immunodeficiency. By Dr. Gouse Mohiddin Shaik

Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias. Original Policy Date

National Medical Policy

Contents SECTION 1: PHYSIOLOGY OF BLOOD

2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes

2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes

Retired Not for Data Submission

Pediatric Hematology-Oncology

Bin them or bank them?

MEDICAL HISTORY FORM ADMINISTRATION INSTRUCTIONS

HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint

Hematopoietic Stem Cell Therapy

1. Penchansky Pediatric Bone Marrow

An Overview of Blood and Marrow Transplantation

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

ASPHO 2019 Review Course January 31-February 2, 2019

Contractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC A. LCD ID Number: L35032 Status: A-Approved

Myelodysplastic Syndrome: Let s build a definition

Regence. Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT REMINDER

Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand

Medical Policy Title ALLOGENEIC HEMATOPOIETIC (STEM) CELL TRANSPLANTATION Policy Number

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

a d u lt s t e m c e l l t r a n s p l a n tat i o n p r o g r a m i n f o r m at i o n f o r pay e r s a n d r e f e r r e r s

HEALTH SERVICES POLICY & PROCEDURE MANUAL

Stem cells. -Dr Dinesh Bhurani, MD, DM, FRCPA. Rajiv Gandhi Cancer Institute, Delhi, -Director, Department of Haematology and BMT

List of Qualifying Conditions

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017

Bone marrow failure. By Zahraa Nasooh Al_Saaty

MOC HEM - General Hematopathology (Mandatory 50-Question Module)

MOC HEM - General Hematopathology (Mandatory 50-Question Module)

Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation. December Reference : NHSCB/B4/a/1

Effective Health Care Program

CERSI MTG BALTIMORE,MD MAY 8,2013 ARNOLD I CAPLAN

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

SAUDI FELLOWSHIP TRAINING PROGRAM. Adult Haematology. Final Written Examination 2019

Hematology Page 1 of 8

DEPARTMENT OF CLINICAL HEMATOLOGY

Tim R. Randolph. PhD, MT(ASCP) Chair and Associate Professor Department of Biomedical Laboratory Science Saint Louis University

Saudi Fellowship Training Program. Final Written Examination of Adult Hematology 2018

Rare Disease Day Brussels, 1 March

Combinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation

MDS: Who gets it and how is it diagnosed?

Supplementary Materials for

Pathology of Hematopoietic and Lymphoid tissue

Stem cell applications- Cord blood, Cord tissue, Fat tissue

BMTCN Review Course Basic Concepts and Indications for Transplantation. David Rice, PhD, RN, NP

Hematology Unit Lab 2 Review Material

Hematopoetic Stem Cell Therapies in TURKIYE

Table of Contents. 1.0 Description of the Procedure, Product, or Service... 1

Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas. James J. Stark, MD, FACP

Clinical Policy Title: Bone marrow transplants

What s New in Newborn Screening?

5/21/2018. Disclosures. Objectives. Normal blood cells production. Bone marrow failure syndromes. Story of DNA

CLIC Sargent Eligibility Criteria

HEMATOLOGIC MALIGNANCIES BIOLOGY

Leukocyte Disorders. Dr Alauldeen Mudhafar Zubair

Immunodeficiency and Skin (September 21, 2018) By (Arti Nanda, MD, DNBE [Kuwait])

HEMATOPOIETIC STEM CELL TRANSPLANT

2 nd step do Bone Marrow Study If possible both the aspiration and

Luke Droney IMMUNOGLOBULIN LEVELS AND FUNCTION

Transcription:

A healthy future is in your hands 01 02 03 04 Standard Therapies - Cord Blood Clinical Trials with Blood - Forming Stem Cells Gene Therapy for Inherited Disorders Using Blood - Forming Stem Cells Clinical Trials with Cord Tissue Stem Cells

01 Standard Therapies - Cord Blood Anaemias Aplastic Anaemia Congenital Dyserythropoietic Anaemia Fanconi Anaemia Paroxysmal Nocturnal Haemoglobinuria (PNH) Leukaemia Acute Leukaemia Acute Lymphoblastic Leukaemia (ALL) Acute Myelogenous Leukaemia (AML) Acute Biphenotypic Leukaemia Acute Undifferentiated Leukaemia Chronic Leukaemia Chronic Myelogenous Leukaemia (CML) Chronic Lymphocytic Leukaemia (CLL) Juvenile Chronic Myelogenous Leukaemia (JCML) Juvenile Myelomonocytic Leukaemia (JMML) Myelodysplastic Syndromes (pre-leukaemia) Refractory Anemia (RA) Refractory Anemia with Ringed Sideroblasts (RARS) Refractory Anemia with Excess Blasts (RAEB) Refractory Anemia with Excess Blasts in Transformation (RAEB-T) Chronic Myelomonocytic Leukemia (CMML) Lymphomas Hodgkin's Lymphoma Non-Hodgkin's Lymphoma (Burkitt's Lymphoma) Bone Marrow Cancers (Plasma Cell Disorders) Multiple Myeloma Plasma Cell Leukaemia Waldenstrom's Macroglobulinemia Solid Tumors (originating outside the blood and immune system) Neuroblastoma Medulloblastoma Retinoblastoma

Continued Myeloproliferative Disorders Acute Myelofibrosis Agnogenic Myeloid Metaplasia (Myelofibrosis) Polycythemia Vera Essential Thrombocythemia Phagocyte Disorders Chediak-Higashi Syndrome Chronic Granulomatous Disease Neutrophil Actin Deficiency Reticular Dysgenesis Inherited Red Cell Abnormalities Beta Thalassemia Major Diamond-Blackfan Anemia Pure Red Cell Aplasia Sickle Cell Disease Inherited Platelet Abnormalities Amegakaryocytosis / Congenital Thrombocytopenia Glanzmann Thrombasthenia Inherited Metabolic Disorders Mucopolysaccharidoses (MPS) Storage Diseases Mucopolysaccharidoses (MPS) Hurler's Syndrome (MPS-IH) Scheie Syndrome (MPS-IS) Hunter's Syndrome (MPS-II) Sanfilippo Syndrome (MPS-III) Morquio Syndrome (MPS-IV) Maroteaux-Lamy Syndrome (MPS-VI) Sly Syndrome, Beta-Glucuronidase Deficiency (MPS-VII) Mucolipidosis II (I-cell Disease) Leukodystrophy Disorders Adrenoleukodystrophy (ALD) / Adrenomyeloneuropathy (AMN) Krabbe Disease (Globoid Cell Leukodystrophy) Metachromatic Leukodystrophy Pelizaeus-Merzbacher Disease

Continued Lysosomal Storage Diseases Niemann-Pick Disease Sandhoff Disease Wolman Disease Other Lesch-Nyhan Syndrome Osteopetrosis Inherited Immune System Disorders Severe Combined Immunodeficiency (SCID) SCID with Adenosine Deaminase Deficiency (ADA-SCID) SCID which is X-linked SCID with absence of T and B Cells SCID with absence of T Cells, Normal B Cells Omenn Syndrome Neutropenias Kostmann Syndrome Myelokathexis Other Ataxia-Telangiectasia Bare Lymphocyte Syndrome Common Variable Immunodeficiency DiGeorge Syndrome Hemophagocytic Lymphohistiocytosis Leukocyte Adhesion Deficiency Lymphoproliferative Disorders (LPD) Lymphoproliferative Disorder, X-linked Wiskott-Aldrich Syndrome Inherited Disorders effecting the Immune System and Other Organs Cartilage-Hair Hypoplasia Gunther's Disease (Erythropoietic Porphyria) Hermansky-Pudlak Syndrome Pearson's Syndrome Shwachman-Diamond Syndrome Systemic Mastocytosis

02 Clinical Trials with Blood - Forming Stem Cells Neurologic Disorder Cerebral Palsy Hypoxic Ischemic Encephalopathy (HIE) Spinal Cord Injury Autism Hearing Loss (acquired sensorineural) Autoimmune Disorders Amyotrophic Lateral Sclerosis (ALS) Crohn's Disease Diabetes Type 1 Graft-versus-Host-Disease (GVHD) Kidney Plus Stem Cell Transplant Lupus Multiple Sclerosis Rheumatiod Arthritis Scleroderma Cardiovascular Congenital Defects Support for Misc. Open Heart Surgery Hypoplastic Left Heart Syndrome (HLHS) Grow Vascular Graft Ischemia Critical Limb Ischemia (CLI) Compartment Syndrome (Battlefield Trauma) Ischemic stroke Ischemic Heart Disease Cardiac Repair Myocardial Infarction Cardiomyopathay

03 Gene Therapy for Inherited Disorders Using Blood - Forming Stem Cells Adrenoleukodystrophy Chronic Granulomatous Disease (X-linked) Fanconi Anemia HIV Metachromatic Leukodystrophy Severe Combined Immunodeficiency Thalassemia Sickle Cell Wiskott-Aldrich Syndrome Orthopedic Alveolar Cleft Palate Repair Knee Cartilage Repair Miscellaneous Epidermolysis Bullosa AIDS Lysosomal Storage Disease Bronchopulmonary Dysplasia (BPD) 04 Clinical Trials with Cord Tissue Stem Cells Alzheimer's Disease Aplastic Anemia Cerebral Palsy Diabetes, Type 2 Liver Failure Multiple Sclerosis Rheumatoid Arthritis Spinal Cord Injury Cartilage Repair Connective Tissue Diseases Erectile Dysfunction Lung Injury Lupus Muscular Dystrophy Myocardial Infarction Osteoarthritis Ovarian failure Parkinson s disease Psoriasis Retinitis pigmentosa Sepsis Stroke Traumatic optic neuropathy Ulcerative colitis

A healthy future is in your hands Future Health Technologies Limited 10 Faraday Building Nottingham Science & Technology Park University Boulevard Nottingham NG7 2QP United Kingdom Tel: +44 115 967 7707 Fax: +44 115 967 7836 info@fhbb.com www.futurehealthbiobank.com Future Health Biobank S.A. Route de Pra de Plan 3 1618 Châtel-St-Denis Switzerland Tel: +41 21 948 29 40 Fax: +41 21 948 29 59 info@futurehealthbiobank.ch www.futurehealthbiobank.ch Future Health Technologies Limited DTL-INT-v3.1